Compare ESLA & DUKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESLA | DUKR |
|---|---|---|
| Founded | 2021 | 2014 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.1M | 20.1M |
| IPO Year | 2021 | 2015 |
| Metric | ESLA | DUKR |
|---|---|---|
| Price | $0.44 | $3.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 10.5K |
| Earning Date | 11-16-2026 | 11-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $377,000.00 |
| Revenue This Year | N/A | $430.50 |
| Revenue Next Year | N/A | $245.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 249.07 |
| 52 Week Low | $0.24 | $3.26 |
| 52 Week High | $3.01 | $7.41 |
| Indicator | ESLA | DUKR |
|---|---|---|
| Relative Strength Index (RSI) | 41.78 | 25.26 |
| Support Level | $0.34 | N/A |
| Resistance Level | $0.51 | $5.85 |
| Average True Range (ATR) | 0.20 | 0.42 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 19.56 | 9.15 |
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.